{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:52:17Z","timestamp":1781081537024,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T00:00:00Z","timestamp":1291852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00296-010-1653-5","type":"journal-article","created":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T10:24:30Z","timestamp":1291803870000},"page":"711-716","source":"Crossref","is-referenced-by-count":38,"title":["Mycophenolate mofetil in juvenile dermatomyositis: a case series"],"prefix":"10.1007","volume":"32","author":[{"given":"Rawane","family":"Dagher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Desjonqu\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Duquesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Quartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Guiguonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Picherot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,9]]},"reference":[{"issue":"Suppl 10","key":"1653_CR1","first-page":"S69","volume":"12","author":"LM Pachman","year":"1994","unstructured":"Pachman LM (1994) Juvenile dermatomyositis (JDMS): new clues to diagnosis and pathogenesis. Clin Exp Rheumatol 12(Suppl 10):S69\u2013S73","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1653_CR2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez EP, Lipton R, Ramsey-Goldman R et al (2003) US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49(3):300\u2013305","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1653_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.bor.0000240362.32089.4c","volume":"18","author":"E Stringer","year":"2006","unstructured":"Stringer E, Feldman BM (2006) Advances in the treatment of juvenile dermatomyositis. Curr Opin Rheumatol 18(5):503\u2013506","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"1653_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1529-8019.2007.00136.x","volume":"20","author":"J Zwerner","year":"2007","unstructured":"Zwerner J, Fiorentino D (2007) Mycophenolate mofetil. Dermatol Ther 20(4):229\u2013238","journal-title":"Dermatol Ther"},{"key":"1653_CR5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1196\/annals.1423.055","volume":"1110","author":"L Iaccarino","year":"2007","unstructured":"Iaccarino L, Arienti S, Rampudda M et al (2007) Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability. Ann N Y Acad Sci 1110:516\u2013524","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1653_CR6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.autrev.2006.11.001","volume":"6","author":"L Iaccarino","year":"2007","unstructured":"Iaccarino L, Rampudda M, Canova M et al (2007) Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 6(3):190\u2013195","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1653_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/0961203308094999","volume":"18","author":"F Falcini","year":"2009","unstructured":"Falcini F, Capannini S, Martini G et al (2009) Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. Lupus 18(2):139\u2013143","journal-title":"Lupus"},{"issue":"1","key":"1653_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archderm.142.1.65","volume":"142","author":"JC Edge","year":"2006","unstructured":"Edge JC, Outland JD, Dempsey JR, Callen JP (2006) Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol 142(1):65\u201369","journal-title":"Arch Dermatol"},{"issue":"8","key":"1653_CR9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.wnl.0000208416.32471.c0","volume":"66","author":"J Rowin","year":"2006","unstructured":"Rowin J, Amato AA, Deisher N et al (2006) Mycophenolate mofetil in dermatomyositis: is it safe? Neurology 66(8):1245\u20131247","journal-title":"Neurology"},{"issue":"2","key":"1653_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2009.04.003","volume":"9","author":"MG Danieli","year":"2009","unstructured":"Danieli MG, Calcabrini L, Calabrese V et al (2009) Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. Autoimmun Rev 9(2):124\u2013127","journal-title":"Autoimmun Rev"},{"key":"1653_CR11","doi-asserted-by":"crossref","unstructured":"Ruperto N, Ravelli A, Pistorio A et al (2008) The provisional Paediatric Rheumatology International Trials Organisation\/American College of Rheumatology\/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 59(1):4\u201313","DOI":"10.1002\/art.23248"},{"issue":"1","key":"1653_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V et al (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43(1):49\u201354","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1653_CR13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0190-9622(98)70496-7","volume":"38","author":"MA Dawkins","year":"1998","unstructured":"Dawkins MA, Jorizzo JL, Walker FO et al (1998) Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol 38(3):397\u2013404","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1653_CR14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2133.2004.05563.x","volume":"150","author":"E Dauden","year":"2004","unstructured":"Dauden E, Sanchez-Peinado C, Ruiz-Genao D et al (2004) Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis. Br J Dermatol 150(1):132\u2013135","journal-title":"Br J Dermatol"},{"issue":"5","key":"1653_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00467-003-1133-1","volume":"18","author":"G Filler","year":"2003","unstructured":"Filler G, Hansen M, LeBlanc C et al (2003) Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol 18(5):445\u2013449","journal-title":"Pediatr Nephrol"},{"key":"1653_CR16","doi-asserted-by":"crossref","unstructured":"Macedo PA, Garcia CB, Schmitz MK et al (2010) Juvenile systemic lupus erythematosus and dermatomyositis associated with urticarial vasculitis syndrome: a unique presentation. Rheumatol Int. doi: 10.1007\/s00296-010-1484-4","DOI":"10.1007\/s00296-010-1484-4"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1653-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1653-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1653-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T12:31:55Z","timestamp":1592137915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1653-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1653-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,9]]}}}